Skip to main content

Table 1 miR-3613 is significantly deleted in 13 independent cancer types

From: MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer

Cancer type Q-value Overall frequency (%)
Prostate adenocarcinoma 2.41×10-47 44.51
Bladder urothelial carcinoma 1.78×10-29 37.01
Liver hepatocellular carcinoma 8.42×10-23 48.11
Glial cancers 1.34×10-17 36.06
Breast invasive adenocarcinoma 1.29×10-16 46.11
Glioblastoma multiforme 3.7×10-12 42.98
Cervical squamous cell carcinoma 3.5×10-11 38.98
Head and neck squamous cell carcinoma 2.55×10-7 40.42
Brain lower grade glioma 2.23×10-5 28.27
Ovarian serous cystadenocarcinoma 2.63×10-5 62.52
Lung squamous cell carcinoma 4.49×10-3 68.06
Lung adenocarcinoma 1.84×10-2 53.88
Diffuse large B cell lymphoma 1.3×10-1 14.58
  1. Significance (Q-value): Low Q-values (< 0.25) suggest that deletions at this locus are enriched by selective pressures and this locus has a possible role in cancer initiation, growth, or survival. Overall frequency: Overall frequency measures the fraction of cancers which exhibit any deletion at this locus